Baseline blood volume identified by dynamic contrast-enhanced computed tomography as a new independent prognostic factor in metastatic renal cell carcinoma()

BACKGROUND: Preliminary data showed prognostic impact of contrast-enhanced computed tomography (DCE-CT) identified Blood Volume (BV) in patients with metastatic renal cell carcinoma (mRCC). BV as an independent prognostic factor remains to be assessed. MATERIALS AND METHODS: DCE-CT identified BV was...

Descripción completa

Detalles Bibliográficos
Autores principales: Drljevic-Nielsen, Aska, Rasmussen, Finn, Mains, Jill R., Thorup, Kennet, Donskov, Frede
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350156/
https://www.ncbi.nlm.nih.gov/pubmed/32653813
http://dx.doi.org/10.1016/j.tranon.2020.100829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350156/
https://www.ncbi.nlm.nih.gov/pubmed/32653813
http://dx.doi.org/10.1016/j.tranon.2020.100829

Ejemplares similares